Search

Your search keyword '"Brown, David M."' showing total 1,916 results

Search Constraints

Start Over You searched for: Author "Brown, David M." Remove constraint Author: "Brown, David M."
1,916 results on '"Brown, David M."'

Search Results

4. Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming

6. TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2

7. SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel Guidance

9. Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials

12. Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

14. Accurate and Efficient Modeling of the Transverse Mode Instability in High Energy Laser Amplifiers

15. Biosimilar Candidate CT-P42 in Diabetic Macular Edema: 24-Week Results from a Randomized, Active-Controlled, Phase III Study

19. Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials

20. Epidemiology and Sequence-Based Evolutionary Analysis of Circulating Non-Polio Enteroviruses

23. Starbug fibre positioning robots: performance and reliability enhancements

26. Contemporary Circulating Enterovirus D68 Strains Have Acquired the Capacity for Viral Entry and Replication in Human Neuronal Cells

28. Tree-rings reveal two strong solar proton events in 7176 and 5259 BCE

32. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

33. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

35. The Influence of Acute Oral Lactate Supplementation on Responses to Cycle Ergometer Exercise: A Randomized, Crossover Pilot Clinical Trial.

38. Evolution of a US County System for Acute Comprehensive Stroke Care

41. TENAYA and LUCERNE

47. Radiocarbon chronology of Iron Age Jerusalem reveals calibration offsets and architectural developments.

Catalog

Books, media, physical & digital resources